Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519).

MLA

Johnson, Peter W. M., et al. “Comparison of ABVD and Alternating or Hybrid Multidrug Regimens for the Treatment of Advanced Hodgkin’s Lymphoma: Results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519).” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 23, no. 36, Dec. 2005, pp. 9208–18. EBSCOhost, https://doi.org/10.1200/JCO.2005.03.2151.

APA

Johnson, P. W. M., Radford, J. A., Cullen, M. H., Sydes, M. R., Walewski, J., Jack, A. S., MacLennan, K. A., Stenning, S. P., Clawson, S., Smith, P., Ryder, D., & Hancock, B. W. (2005). Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin’s lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 23(36), 9208–9218. https://doi.org/10.1200/JCO.2005.03.2151

Chicago

Johnson, Peter W M, John A Radford, Michael H Cullen, Matthew R Sydes, Jan Walewski, Andrew S Jack, Kenneth A MacLennan, et al. 2005. “Comparison of ABVD and Alternating or Hybrid Multidrug Regimens for the Treatment of Advanced Hodgkin’s Lymphoma: Results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519).” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 23 (36): 9208–18. doi:10.1200/JCO.2005.03.2151.